These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 35787806)

  • 1. Corrigendum to "Cognitive-behavioral social skills training for patients with late-life schizophrenia and the moderating effect of executive dysfunction" [Schizophr. Res. 239 (2022) 160-167].
    Rajji TK; Mamo DC; Holden J; Granholm E; Mulsant BH
    Schizophr Res; 2023 Jun; 256():136. PubMed ID: 35787806
    [No Abstract]   [Full Text] [Related]  

  • 2. Cognitive-Behavioral Social Skills Training for patients with late-life schizophrenia and the moderating effect of executive dysfunction.
    Rajji TK; Mamo DC; Holden J; Granholm E; Mulsant BH
    Schizophr Res; 2022 Jan; 239():160-167. PubMed ID: 34896870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corrigendum to "Phenotype continuum between autism and schizophrenia: Evidence from the Movie for the Assessment of the social cognition (MASC)" [Schizophr. Res. 185 (2017) 161-166].
    Martinez G; Alexandre C; Mam-Lam-Fook C; Bendjemaa N; Gaillard R; Garel P; Dziobek I; Amado I; Krebs MO
    Schizophr Res; 2018 Mar; 193():489. PubMed ID: 29550055
    [No Abstract]   [Full Text] [Related]  

  • 4. Corrigendum to "Increased diffusivity in gray matter in recent onset schizophrenia is associated with clinical symptoms and social cognition" [Schizophr. Res. 176 (2-3) (Oct 2016) 144-150].
    Lee JS; Kim CY; Joo YH; Newell D; Bouix S; Shenton ME; Kubicki M
    Schizophr Res; 2017 Mar; 181():137. PubMed ID: 27890401
    [No Abstract]   [Full Text] [Related]  

  • 5. A randomized, controlled trial of cognitive behavioral social skills training for middle-aged and older outpatients with chronic schizophrenia.
    Granholm E; McQuaid JR; McClure FS; Auslander LA; Perivoliotis D; Pedrelli P; Patterson T; Jeste DV
    Am J Psychiatry; 2005 Mar; 162(3):520-9. PubMed ID: 15741469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corrigendum to "Self and time in individuals with schizophrenia: A motor component?" [Schizophr. Res. 272 (2024) 12-19 (October)].
    Foerster FR; Joos E; Martin B; Coull JT; Giersch A
    Schizophr Res; 2024 Oct; 274():269. PubMed ID: 39395269
    [No Abstract]   [Full Text] [Related]  

  • 7. Corrigendum to "Efficacy of brexpiprazole in patients with acute schizophrenia: Review of three randomized, double-blind, placebo-controlled studies" [Schizophr. Res. 174 (2016) 82-92].
    Correll CU; Skuban A; Hobart M; Ouyang J; Weiller E; Weiss C; Kane JM
    Schizophr Res; 2017 Dec; 190():191-194. PubMed ID: 28351543
    [No Abstract]   [Full Text] [Related]  

  • 8. Corrigendum to "Long-term cariprazine treatment for the prevention of relapse in patients with schizophrenia: A randomized, double-blind, placebo-controlled trial" [Schizophr. Res. 176 (2016) 264-271].
    Durgam S; Earley W; Li R; Li D; Lu K; Laszlovszky I; Wolfgang Fleischhacker W; Nasrallah HA
    Schizophr Res; 2018 Feb; 192():493. PubMed ID: 28427929
    [No Abstract]   [Full Text] [Related]  

  • 9. Corrigendum to "Natural language processing for defining linguistic features in schizophrenia: A sample from Turkish speakers" [Schizophr. Res. 266 (2024) 183-189].
    Çabuk T; Sevim N; Mutlu E; Yağcıoğlu AEA; Koç A; Toulopoulou T
    Schizophr Res; 2024 Sep; 274():178-179. PubMed ID: 39317121
    [No Abstract]   [Full Text] [Related]  

  • 10. Corrigendum to "Long-term hospitalizations for schizophrenia in the Czech Republic 1998-2012" (Schizophr. Res. vol. 175, issues 1-3, August 2016, pages 180-185).
    PetrWinkler ; Mladá K; Krupchanka D; Agius M; Ray MK; Höschl C
    Schizophr Res; 2016 Oct; 176(2-3):581. PubMed ID: 27476650
    [No Abstract]   [Full Text] [Related]  

  • 11. Corrigendum to "Revisiting the latent structure of negative symptoms in schizophrenia: Evidence from two second-generation clinical assessments" [Schizophr. Res. 248 (2022) 131-139].
    Li SB; Liu C; Zhang JB; Wang LL; Hu HX; Chu MY; Wang Y; Lv QY; Lui SSY; Cheung EFC; Yi ZH; Chan RCK
    Schizophr Res; 2023 Feb; 252():206-207. PubMed ID: 36657365
    [No Abstract]   [Full Text] [Related]  

  • 12. Corrigendum to "resilience in schizophrenia: A comparative study between a remote island and an urban area in Japan" [Schizophr. Res. Volume 171, Issues 1-3, March 2016, Pages 92-96].
    Yoshida K; Suzuki T; Imasaka Y; Kubo KI; Mizuno Y; Saruta J; Tsukinoki K; Mimura M; Uchida H
    Schizophr Res; 2016 Oct; 176(2-3):580. PubMed ID: 27539074
    [No Abstract]   [Full Text] [Related]  

  • 13. Letter to the Editor: THE IMPACT OF THE COVID-19 PANDEMIC ON SCHIZOPHRENIA PATIENTS.
    Hoşgelen EI; Alptekin K
    Turk Psikiyatri Derg; 2021; 32(3):219-221. PubMed ID: 34750798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Letter to the Editor: THE IMPACT OF THE COVID-19 PANDEMIC ON SCHIZOPHRENIA PATIENTS.
    Hoşgelen EI; Alptekin K
    Turk Psikiyatri Derg; 2021; 32(3):219-221. PubMed ID: 34637131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Symptoms versus neurocognition as predictors of change in life skills in schizophrenia after outpatient rehabilitation.
    Kurtz MM; Wexler BE; Fujimoto M; Shagan DS; Seltzer JC
    Schizophr Res; 2008 Jul; 102(1-3):303-11. PubMed ID: 18495433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corrigendum to "Morphometric analysis of the cerebral expression of ATP-binding cassette transporter protein ABCB1 in chronic schizophrenia: Circumscribed deficits in the habenula" [Schizophr. Res. 2016 Nov;177(1-3):52-58].
    Bernstein HG; Hildebrandt J; Dobrowolny H; Steiner J; Bogerts B; Pahnke J
    Schizophr Res; 2018 Jul; 197():622-623. PubMed ID: 29636286
    [No Abstract]   [Full Text] [Related]  

  • 17. A brief cognitive-behavioural social skills training for stabilised outpatients with schizophrenia: a preliminary study.
    Rus-Calafell M; Gutiérrez-Maldonado J; Ortega-Bravo M; Ribas-Sabaté J; Caqueo-Urízar A
    Schizophr Res; 2013 Feb; 143(2-3):327-36. PubMed ID: 23235141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corrigendum to "Long-term efficacy and safety of once-monthly Risperidone ISM® in the treatment of schizophrenia: Results from a 12-month open-label extension study" [Schizophr. Res. 239 (2022) 83-91].
    Filts Y; Litman RE; Martínez J; Anta L; Naber D; Correll CU
    Schizophr Res; 2022 Aug; 246():258-259. PubMed ID: 35853294
    [No Abstract]   [Full Text] [Related]  

  • 19. Corrigendum to "Facial, vocal and cross-modal emotion processing in early-onset schizophrenia spectrum disorder" [Schizophr. Res. (Aug. 18, 2015) pii: S0920-9964(15)00405-3. doi: 10. 1016/j.schres.2015.07.039].
    M G; J X; A F; N B; C L; D C; L C
    Schizophr Res; 2015 Dec; 169(1-3):508. PubMed ID: 28760563
    [No Abstract]   [Full Text] [Related]  

  • 20. The efficacy of computer-based cognitive training for executive dysfunction in schizophrenia.
    Mak M; Tyburski E; Starkowska A; Karabanowicz E; Samochowiec A; Samochowiec J
    Psychiatry Res; 2019 Sep; 279():62-70. PubMed ID: 31302353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.